THESE REAGENTS ARE REQUIRED FOR SHORT READ SEQUENCING ON ILLUMINA INSTRUMENTS. Solicitation ID/Procurement Identifier: 75N92020D00022 Ultimate Completion Date: Tue Sep 02 17:00:00 GMT 2025
The reagents are required to perform ANA testing on the AFT3000 and Image Navigator instruments. Delivery period is 1 October 2020 to 30 September 2021. The exact quantity and type of reagents purchased cannot be predicted and is based on mission requirements during the delivery period.
The United States Air Force School of Aerospace Medicine Epidemiology Laboratory (USAFSAM/PHE) is seeking an IDIQ contract to procure vendor supported reagents/consumables/kits necessary to perform innovative biological testing technologies. These reagents are required for laboratory diagnostic testing support for 213 DoD MTFs and 9 million patients/beneficiaries.
Bio-Rad Laboratories, consumables and reagents are required in order to maintain a continuity of equipment and standardization of repair parts to an existing infrastructure, and Bio-Rad Laboratories is the proprietary manufacturer of the equipment. In accordance with FAR 5.207, all responsible sources may submit a bid, proposal or quotation which shall be considered by the agency, however, THIS NOTICE IS FOR INFORMATIONAL PURPOSES ONLY.
These reagents cannot be procured from any other source and are required for sample preparation for the Illumina MiSeq.
The brand name reagents are required (manufacturers include the following: Alere, Bayer Diagnostics, Bio laboratories, American Master Tech Scientific, Beckman Coulter, Bio Test Medical, Azer Scientific, Becton Dickinson, BioMerieux Vitek, Cancer Diagnostics, Fisher Scientific, Immucor Gamma, Lav Pulse Med/Energy Beam Sci 2, Ortho Clinical Diagnostics, Polymed Co, Remel, Simmler, Terumo, Trinity Biotech, Whatman, Dynarex, Globe Scientific, Kimberly
These instruments and reagents are required to support the screening and detection of mutations causing genetic diseases in newborn Floridians. In accordance with Chapter 383.14, Florida Administrative Code, the Florida Department of Health, BPHL, requests authorization as a single source, the MiSeq® System reagent, instrumentation, service for Cystic Fibrosis (CF) testing, from Illumina, Inc.
